Accelerate IND timelines with high‑productivity, IP‑friendly CHO cell line development.
ProBio’s Cell Line Development (CLD) platform helps innovators reach IND milestones faster with a high‑performance, biotech‑friendly solution designed for speed, productivity, and reliability.
Key Advantages
- Fast CLD timelines: 10–14 weeks from gene synthesis to Primary Cell Bank (PCB)–stage clones.
- High pre‑process titers: Strong productivity early, reducing downstream risk.
- Proprietary CHO platforms: Includes a FUT8‑knockout ADCC‑enhanced line.
- IP‑friendly: Royalty‑free model with IP‑free afucosylated antibody production.
- Stable & scalable: Robust clone performance supports smooth scale‑up.
- Flexible for multiple modalities: mAbs, bispecifics, Fc‑engineered molecules, recombinant proteins.
Explore the flyer to see how ProBio’s high‑titer performance and accelerated workflows can speed your path to IND readiness.
Offered Free by: ProBio
See All Resources from: ProBio
